Ligand Pharmaceuticals Inc (NASDAQ:LGND)
| 73.54 Delayed Data As of Mar 31 |  +2.14 / +3.00%Today’s Change | 45.25 Today|||52-Week Range 83.95 | +10.09% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Higgins John L Chief Executive Officer |  Sale | 11/17/2022 | 10,000 | $78.32 | $783.2K | -6.11% |
Higgins John L Director | Sale | 12/16/2022 | 10,000 | $61.87 | $618.7K | +17.41% |
Higgins John L Director | Sale | 12/28/2022 | 5,289 | $66.29 | $350.6K | +10.97% |
Higgins John L Chief Executive Officer | Sale | 9/16/2022 | 3,000 | $89.35 | $268.1K | -16.27% |
Korenberg Matthew Edward President & Chief Operating Officer | Sale | 12/28/2022 | 3,859 | $66.29 | $255.8K | +10.97% |
Higgins John L Director |  Buy | 12/12/2022 | 20,000 | $12.78 | $255.6K | +13.52% |
Higgins John L Director | Sale | 12/12/2022 | 3,944 | $64.80 | $255.6K | +13.52% |
Korenberg Matthew Edward President & Chief Operating Officer | Sale | 2/15/2023 | 2,890 | $72.98 | $210.9K | +0.79% |
Foehr Matthew William President & Chief Operating Officer | Buy | 5/13/2022 | 2,500 | $82.76 | $206.9K | -14.43% |
Higgins John L Chief Executive Officer | Sale | 9/15/2022 | 2,000 | $90.00 | $180.0K | -18.38% |
Page of 4